Atlas Trials

Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I

Clinical trial NCT03665636 · COMPLETED

Trial details

NCT number
NCT03665636
Sponsor
Areeg El-Gharbawy
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Glycogen Storage Disease Type I
Start date
2020-10-16
Primary completion
2021-10-21
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.